These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4205947)

  • 1. Vi antigen from Salmonella typhosa and immunity against typhoid fever. I. Isolation and immunologic properties in animals.
    Wong KH; Feeley JC; Northrup RS; Forlines ME
    Infect Immun; 1974 Feb; 9(2):348-53. PubMed ID: 4205947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adhesion of Vi antigen and toxicity in typhoid vaccines inactivated by acetone or by heat and phenol.
    Wong KH; Feeley JC; Pittman M; Forlines ME
    J Infect Dis; 1974 May; 129(5):501-6. PubMed ID: 4207306
    [No Abstract]   [Full Text] [Related]  

  • 3. Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.
    Levin DM; Wong KH; Reynolds HY; Sutton A; Northrup RS
    Infect Immun; 1975 Dec; 12(6):1290-4. PubMed ID: 54336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Production of a complex chemical typhoid vaccine containing O-, Vi, and H-antigens].
    Gekker VD; Sergeeva NS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Jan; 50(1):14-8. PubMed ID: 4780106
    [No Abstract]   [Full Text] [Related]  

  • 5. [The safety of a new chemical typhoid preparation containing a complex of Vi and K antigens in tests of its acute and chronic toxicity].
    Kharitonova AM; Grigor'eva LV; Bykovskaia SI; Ageeva VA; Stepanova LK; Belaia IuA
    Zh Mikrobiol Epidemiol Immunobiol; 1992; (9-10):57-60. PubMed ID: 1481607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunochemical study of the antigenic complexes from typhoid-paratyphoid A and B bacteria obtained industrially].
    Khatuntseva NV; Mironova MV; Riapolova RG; Rybasova GV
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jun; 51(6):50-5. PubMed ID: 4409774
    [No Abstract]   [Full Text] [Related]  

  • 7. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi.
    Robbins JD; Robbins JB
    J Infect Dis; 1984 Sep; 150(3):436-49. PubMed ID: 6207249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ineffectiveness of Vi and chemically treated endotoxins as typhoid vaccines in mice challenged with a Salmonella typhosa-Salmonella typhimurium hybrid.
    Diena BB; Ryan A; Wallace R; Ashton FE; Johnson EM; Baron LS
    Infect Immun; 1975 Dec; 12(6):1470-1. PubMed ID: 1107227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purified Vi antigens as possible typhoid vaccines.
    Pistole TG; Marcus S
    Immunol Commun; 1974; 3(3):227-38. PubMed ID: 4606971
    [No Abstract]   [Full Text] [Related]  

  • 10. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A chemical typhoid vaccine containing a surface-antigen complex including the K-antigen].
    Stepanova LK; Belaia IuA; Sergeeva NS; Ageeva VA; Petrukhin VG
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (1):51-6. PubMed ID: 7520650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vi-negative strains of Salmonella typhosa: attempts to induce W-V reversion and the use of non-Vi strains in evaluating typhoid vaccines.
    TULLY JG; CURRIE JA
    J Bacteriol; 1962 Oct; 84(4):747-53. PubMed ID: 13994748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fractionation of S. typhi Vi-antigen preparations by the gel filtration method on sephadex G-200].
    Samsonova VS; Kholchev NV; Alliluev AP; Shandalov BIa; Kliuikova TM
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Oct; 50(10):3-7. PubMed ID: 4207095
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of two Salmonella typhimurium hybrids as challenge organisms in a system for the assay of typhoid vaccines.
    Johnson EM; Diena BB; Lior H; Ryan A; Krol P; Baron LS
    Infect Immun; 1982 Oct; 38(1):201-5. PubMed ID: 6754614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diversity of Vi-related antigens in the microcapsule of Salmonella typhi.
    Szewczyk B; Taylor A
    Infect Immun; 1980 Dec; 30(3):661-7. PubMed ID: 6164644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of typhoid antigens in protection and pathogenicity for mice.
    Diena BB; Baron LS; Johnson EM; Wallace R; Ashton FE
    Infect Immun; 1974 Jun; 9(6):1102-4. PubMed ID: 4598256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effectiveness of the vaccine of Vi-antigen of Salmonella typhosa in children and adolescents].
    D'iachenko PN; Dzhumaliev ND; Koshotov T; Zhoroev Zh
    Zdravookhr Kirg; 1975; (5):49-53. PubMed ID: 1943
    [No Abstract]   [Full Text] [Related]  

  • 19. Differential Killing of Salmonella enterica Serovar Typhi by Antibodies Targeting Vi and Lipopolysaccharide O:9 Antigen.
    Hart PJ; O'Shaughnessy CM; Siggins MK; Bobat S; Kingsley RA; Goulding DA; Crump JA; Reyburn H; Micoli F; Dougan G; Cunningham AF; MacLennan CA
    PLoS One; 2016; 11(1):e0145945. PubMed ID: 26741681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agar plaque formation by mouse spleen cells in response to vaccination with Vi antigen and typhoid vaccines.
    Esposito VM
    J Bacteriol; 1969 Jul; 99(1):356-7. PubMed ID: 5802616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.